India's pharmaceutical regulatory landscape is undergoing significant transformation. In January 2026, the Government of India notified key amendments to the New Drugs & Clinical Trials (NDCT) Rules, introducing changes that…
India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…
Importing generic medicines from India can deliver substantial savings, but the regulatory landscape is complex and varies significantly by destination country. This guide walks buyers through the key regulatory requirements,…
Buying Indian generic medicines across borders is one of the smartest ways to cut long-term healthcare costs, but the process is only smooth when you understand the customs, documentation and…